[{"NetIncomeLoss_2_Q2_USD":-44200000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":0.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":0.0,"MarketableSecuritiesCurrent_0_Q2_USD":46000000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PrepaidTaxes_0_Q2_USD":18600000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-100000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-300000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":50100000.0,"StockRepurchasedAndRetiredDuringPeriodShares_2_Q2_shares":0.0,"Liabilities_0_Q2_USD":457900000.0,"GoodwillAndIntangibleAssetImpairment_1_Q2_USD":1800000.0,"GoodwillAndIntangibleAssetImpairment_2_Q2_USD":1800000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1176900000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":83900000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":118400000.0,"OtherAssetsNoncurrent_0_Q2_USD":4800000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":13500000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":29000000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":8100000.0,"GoodwillWrittenOffRelatedToSaleOfBusinessUnit_2_Q2_USD":88500000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-5100000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q2_USD":4800000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-45900000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":26.25,"DepreciationAndAmortization_1_Q2_USD":16900000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":36600000.0,"LongTermDebtCurrent_0_Q2_USD":104100000.0,"AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_0_Q2_USD":225700000.0,"LongTermDebt_0_Q2_USD":104100000.0,"AssetsCurrent_0_Q2_USD":538900000.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":-600000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_2_Q2_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":24.81,"StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0_Q2_USD":110700000.0,"Depreciation_1_Q2_USD":3400000.0,"Depreciation_2_Q2_USD":6300000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":9300000.0,"IncomeTaxesPaid_2_Q2_USD":1700000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-4000000.0,"InterestPaidNet_2_Q2_USD":1700000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_2_Q2_USD":6800000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":90900000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":0.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":0.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedRoyaltiesCurrent_0_Q2_USD":5000000.0,"DepreciationAndAmortization_2_Q2_USD":35300000.0,"IncreaseDecreaseInPrepaidExpensesOther_2_Q2_USD":4700000.0,"IncreaseDecreaseInInventories_2_Q2_USD":800000.0,"CostsAndExpenses_1_Q2_USD":210200000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":18700000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":16100000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":77200000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":76600000.0,"InventoryWriteDown_1_Q2_USD":6600000.0,"InventoryWriteDown_2_Q2_USD":6600000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-300000.0,"MinorityInterest_0_Q2_USD":-100000.0,"ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_1_Q2_USD":13300000.0,"ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_2_Q2_USD":13200000.0,"InvestmentsAndCash_0_Q2_USD":184300000.0,"EarningsPerShareBasic_1_Q2_USD":-0.06,"EarningsPerShareBasic_2_Q2_USD":-0.58,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":282900000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":23.42,"ResearchAndDevelopmentExpense_1_Q2_USD":19500000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":42600000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":2700000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-9200000.0,"DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_0_Q2_USD":119900000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-5100000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":18800000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":25000000.0,"AccountsReceivableNetCurrent_0_Q2_USD":94800000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":900000.0,"CostsAndExpenses_2_Q2_USD":430000000.0,"MinorityInterestPeriodIncreaseDecrease_1_Q2_USD":-100000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q2_USD":400000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":1300000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_2_Q2_USD":3300000.0,"RecordedUnconditionalPurchaseObligation_0_Q2_USD":5900000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-75000000.0,"OtherSundryLiabilitiesNoncurrent_0_Q2_USD":5300000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q2_USD":45800000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":-0.237,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2_Q2_USD":-1300000.0,"RevenueRemainingPerformanceObligation_0_Q2_USD":6700000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":618100000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":100000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q2_USD":19900000.0,"ProceedsFromIncomeTaxRefunds_2_Q2_USD":89900000.0,"RepaymentsOfLinesOfCredit_2_Q2_USD":120000000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q2_security":0.0,"CommonStockValue_0_Q2_USD":800000.0,"NumberOfReportableSegments_2_Q2_segment":2.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_0_Q2_USD":0.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-9200000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":280300000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":134800000.0,"FairValueNetAssetLiability_0_Q2_USD":115400000.0,"DeconsolidationGainOrLossAmount_2_Q2_USD":0.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":19900000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":46000000.0,"PaymentsToAcquireProductiveAssets_2_Q2_USD":11600000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":0.0,"DebtInstrumentUnamortizedDiscountCurrent_0_Q2_USD":2300000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":77200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":76600000.0,"GainLossOnDispositionOfAssets1_2_Q2_USD":32400000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":67400000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-300000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-1400000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":8900000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":600000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-3800000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-53400000.0,"Goodwill_0_Q2_USD":240100000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-400000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":102900000.0,"IncreaseDecreaseInPrepaidTaxes_2_Q2_USD":-89800000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.06,"LiabilitiesCurrent_0_Q2_USD":271000000.0,"EarningsPerShareDiluted_2_Q2_USD":-0.58,"AccountsPayableCurrent_0_Q2_USD":28500000.0,"NonoperatingIncomeExpense_2_Q2_USD":14100000.0,"NetIncomeLoss_1_Q2_USD":-4700000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":43200000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":8500000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":58200000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":541900000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":2100000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":902400000.0,"IncreaseDecreaseInDeferredIncomeTaxes_2_Q2_USD":11500000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":0.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":0.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":426800000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":17500000.0,"LongTermDebtNoncurrent_0_Q2_USD":0.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":118400000.0,"IncreaseDecreaseInOtherReceivables_2_Q2_USD":-300000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":17700000.0,"CapitalizedContractCostGross_0_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":118400000.0,"InterestExpense_1_Q2_USD":2000000.0,"InterestExpense_2_Q2_USD":5000000.0,"NonoperatingIncomeExpense_1_Q2_USD":17000000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":1200000.0,"CommonStockSharesOutstanding_0_Q2_shares":77700000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":12300000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":1400000.0,"InventoryNet_0_Q2_USD":17700000.0,"ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_2_Q2_USD":0.0,"OperatingIncomeLoss_1_Q2_USD":-20800000.0,"OperatingIncomeLoss_2_Q2_USD":-67500000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":189400000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":362500000.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_0_Q2_USD":0.0,"ProceedsFromSaleOfProductiveAssets_2_Q2_USD":32500000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q2_USD":19700000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_0_Q2_USD":12200000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":86600000.0,"ShareBasedCompensation_2_Q2_USD":17900000.0,"Assets_0_Q2_USD":1360300000.0,"CommonStockSharesIssued_0_Q2_shares":77700000.0,"UnrecognizedTaxBenefits_0_Q2_USD":31000000.0,"DebtInstrumentUnamortizedDiscountNoncurrent_0_Q2_USD":0.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":23500000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7000000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q2_USD":8500000.0,"InvestmentIncomeInterest_2_Q2_USD":400000.0,"InvestmentIncomeInterest_1_Q2_USD":200000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_2_Q2_USD":3300000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-271200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":2400000.0,"TaxesPayableCurrent_0_Q2_USD":3700000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":3000000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_2_Q2_USD":400000.0,"StockholdersEquity_0_Q2_USD":902500000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":13800000.0,"ProfitLoss_1_Q2_USD":-4700000.0,"ProfitLoss_2_Q2_USD":-44200000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":40500000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-45900000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":12700000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":3400000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":8900000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":17900000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":50700000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":1360300000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":22.93,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":824800000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":22600000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":146100000.0,"InventoryFirmPurchaseCommitmentLoss_1_Q2_USD":5900000.0,"Ticker":"MYGN","CIK":"899923","name":"MYRIAD GENETICS INC","OfficialName":"Myriad Genetics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"1850258412.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20210804"}]